Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000563119 | SCV000673833 | likely benign | Hereditary cancer-predisposing syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001392074 | SCV001593707 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2023-07-16 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000563119 | SCV002528659 | likely benign | Hereditary cancer-predisposing syndrome | 2021-10-12 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV005248329 | SCV005898921 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2024-11-22 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Department of Pathology and Laboratory Medicine, |
RCV005357706 | SCV005916829 | likely benign | Muir-Torré syndrome | 2023-09-26 | criteria provided, single submitter | clinical testing |